Cardiology fellow with a passion for HF π« | CV Fellow @DukeCardFellows | #GradyMade@EmoryMedicine | Emory School of Medicine β22 | University of Chicago β15
Yesterday, I presented my Senior Grand Rounds on the impact of race/ethnicity in HFrEF presentation, management, and candidacy for advanced HF therapies. Here are some key takeaways:
Choosing among invasive and non-invasive monitors π« Dr. Alexander Hajduczok (@AHajduczok): the opportunity is the C to D transition. Invasive PA monitoring has the strongest data, wearables may add scale, and we need more data on who gets what π§΅ #ChiHemos2026@ChiHForum
Session V: Hemodynamic Implementation π« Dr. Scott Lundgren (@swlundgren) on putting remote PA pressure data into clinical workflow. No trials to lean on, so itβs best practice: right patients, a dedicated team, standardized review π§΅ #ChiHemos2026@ChiHForum@Cardionerds
Debate: What is the real pressure? π« Dr. Adriano Tonelli: esophageal manometry is needed. Dr. Yogesh Reddy (@yreddyhf): all you need is a Swan. The crux: does obesity falsely raise PAWP, or is it real HFpEF? π§΅ #ChiHemos2026@ChiHForum@Cardionerds
Session IV: Hemodynamic Interpretation π« Dr. Hoong Sern Lim on myths & misconceptions of RHC: β’ Itβs not hard: 85β90% success with blind floatation β’ Itβs safe: ~0.05% procedural mortality β’ It adds what non-invasive data canβt #ChiHemos2026@ChiHForum@Cardionerds